{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:34:57Z","timestamp":1761921297049,"version":"3.34.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.addbeh.2024.108202","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T21:07:41Z","timestamp":1730927261000},"page":"108202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Exposure to Bupropion-SR vs. Placebo is associated with reductions in smoking among persons receiving methadone with no stated interest in smoking cessation"],"prefix":"10.1016","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3269-5324","authenticated-orcid":false,"given":"Orrin D.","family":"Ware","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxine L.","family":"Stitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Umbricht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly E.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.addbeh.2024.108202_b0005","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/bcp.12116","article-title":"Pharmacotherapy for smoking cessation: Pharmacological principles and clinical practice","volume":"77","author":"Aubin","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"year":"1987","series-title":"BDI, Beck depression inventory : Manual","author":"Beck","key":"10.1016\/j.addbeh.2024.108202_b0010"},{"year":"1996","series-title":"BDI-II, Beck depression inventory : Manual","author":"Beck","key":"10.1016\/j.addbeh.2024.108202_b0015"},{"key":"10.1016\/j.addbeh.2024.108202_b0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12916-015-0505-2","article-title":"Does reduced smoking if you can't stop make any difference?","volume":"13","author":"Begh","year":"2015","journal-title":"BMC Medicine"},{"issue":"5","key":"10.1016\/j.addbeh.2024.108202_b0025","first-page":"CD009329","article-title":"Pharmacological interventions for smoking cessation: An overview and network meta-analysis","volume":"2013","author":"Cahill","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.addbeh.2024.108202_b0085","unstructured":"National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. (2014). The Health Consequences of Smoking\u201450 Years of Progress: A Report of the Surgeon General. Retrieved April 11, 2024 from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK179276\/."},{"issue":"9","key":"10.1016\/j.addbeh.2024.108202_b0030","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/ntr\/ntx189","article-title":"Pilot study of a tailored smoking cessation intervention for individuals in treatment for opioid dependence","volume":"20","author":"Cooperman","year":"2018","journal-title":"Nicotine & Tobacco Research"},{"issue":"7","key":"10.1016\/j.addbeh.2024.108202_b0035","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.21037\/jtd.2020.02.47","article-title":"Cardiovascular risk of smoking and benefits of smoking cessation","volume":"12","author":"Gallucci","year":"2020","journal-title":"Journal of Thoracic Disease"},{"key":"10.1016\/j.addbeh.2024.108202_b0040","doi-asserted-by":"crossref","unstructured":"GBD 2019 Tobacco Collaborators. (2021). Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: A systematic analysis from the Global Burden of Disease Study 2019. Lancet, 397(10292), 2337-2360. 10.1016\/S0140-6736(21)01169-7.","DOI":"10.1016\/S0140-6736(21)01169-7"},{"issue":"9","key":"10.1016\/j.addbeh.2024.108202_b0045","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"British Journal of Addiction"},{"key":"10.1016\/j.addbeh.2024.108202_b0050","doi-asserted-by":"crossref","DOI":"10.1177\/1179173X241254803","article-title":"Smoking policies of outpatient and residential substance use disorder treatment facilities in the united states","volume":"17","author":"Holt","year":"2024","journal-title":"Tobacco Use Insights"},{"issue":"4","key":"10.1016\/j.addbeh.2024.108202_b0055","first-page":"CD000031","article-title":"Antidepressants for smoking cessation","volume":"4","author":"Howes","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.addbeh.2024.108202_b0060","first-page":"CD000031","article-title":"Antidepressants for smoking cessation","volume":"2014","author":"Hughes","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1016\/j.addbeh.2024.108202_b0065","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/ntr\/ntv030","article-title":"Are pharmacotherapies ineffective in opioid-dependent smokers? reflections on the scientific literature and future directions","volume":"17","author":"Miller","year":"2015","journal-title":"Nicotine & Tobacco Research"},{"issue":"9","key":"10.1016\/j.addbeh.2024.108202_b0070","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1158\/1055-9965.EPI-07-0189","article-title":"Validation of self-reported smoking status using saliva cotinine: A rapid semiquantitative dipstick method","volume":"16","author":"Montalto","year":"2007","journal-title":"Cancer Epidemiology, Biomarkers, & Prevention"},{"issue":"4","key":"10.1016\/j.addbeh.2024.108202_b0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/10550490802138814","article-title":"Preliminary study of buprenorphine and bupropion for opioid-dependent smokers","volume":"17","author":"Mooney","year":"2008","journal-title":"American Journal on Addictions"},{"issue":"4","key":"10.1016\/j.addbeh.2024.108202_b0080","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/add.15240","article-title":"Effect of varenicline directly observed therapy versus varenicline self-administered therapy on varenicline adherence and smoking cessation in methadone-maintained smokers: A randomized controlled trial","volume":"116","author":"Nahvi","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2024.108202_b0090","unstructured":"National Institute on Drug Abuse. (2020). Tobacco, nicotine and e-cigarettes research report: What are treatments for tobacco dependence? Retrieved April 11, 2024 from https:\/\/nida.nih.gov\/publications\/research-reports\/tobacco-nicotine-e-cigarettes\/what-are-treatments-tobacco-dependence."},{"issue":"5","key":"10.1016\/j.addbeh.2024.108202_b0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1521-0391.2010.00066.x","article-title":"The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: A pilot study","volume":"19","author":"Poling","year":"2010","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.addbeh.2024.108202_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.208987","article-title":"Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial","volume":"151","author":"Schmitz","year":"2023","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"5","key":"10.1016\/j.addbeh.2024.108202_b0105","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/add.13264","article-title":"Financial incentives to promote extended smoking abstinence in opioid-maintained patients: A randomized trial","volume":"111","author":"Sigmon","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2024.108202_b0110","doi-asserted-by":"crossref","unstructured":"Sobell, L. C., & Sobell, M. B. (1992). Timeline follow-back: A technique for assessing self-reported alcohol consumption. In Measuring alcohol consumption: Psychosocial and biochemical methods. (pp. 41-72). Humana Press\/Springer Nature. 10.1007\/978-1-4612-0357-5_3.","DOI":"10.1007\/978-1-4612-0357-5_3"},{"issue":"2","key":"10.1016\/j.addbeh.2024.108202_b0115","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.drugalcdep.2013.07.005","article-title":"Varenicline for smoking cessation among methadone-maintained smokers: A randomized clinical trial","volume":"133","author":"Stein","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.addbeh.2024.108202_b0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1037\/pha0000185","article-title":"Tobacco withdrawal among opioid-dependent smokers","volume":"26","author":"Streck","year":"2018","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"6","key":"10.1016\/j.addbeh.2024.108202_b0125","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1037\/pha0000350","article-title":"Investigating tobacco withdrawal in response to reduced nicotine cigarettes among smokers with opioid use disorder and other vulnerabilities","volume":"28","author":"Streck","year":"2020","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.addbeh.2024.108202_bib141","doi-asserted-by":"crossref","unstructured":"Ware OD, Sweeney MM, Cunningham C, Umbricht A, Stitzer M, Dunn KE. Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2023 Mar 1;6(3):e232278. doi: 10.1001\/jamanetworkopen.2023.2278.","DOI":"10.1001\/jamanetworkopen.2023.2278"},{"issue":"2","key":"10.1016\/j.addbeh.2024.108202_b0135","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/10826084.2017.1342661","article-title":"Smoking Cessation Among Methadone-Maintained Patients: A Meta-Analysis","volume":"53","author":"Yee","year":"2018","journal-title":"Subst Use & Misuse"},{"issue":"1","key":"10.1016\/j.addbeh.2024.108202_b0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/1874473711306010009","article-title":"Cigarette smoking in methadone maintained patients: An up-to-date review","volume":"6","author":"Zirakzadeh","year":"2013","journal-title":"Current Drug Abuse Reviews"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030646032400251X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030646032400251X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T12:39:17Z","timestamp":1738154357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030646032400251X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":28,"alternative-id":["S030646032400251X"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2024.108202","relation":{},"ISSN":["0306-4603"],"issn-type":[{"type":"print","value":"0306-4603"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposure to Bupropion-SR vs. Placebo is associated with reductions in smoking among persons receiving methadone with no stated interest in smoking cessation","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2024.108202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108202"}}